TESTICULAR CANCER - ED2
Hodder Arnold (Verlag)
978-0-412-61210-7 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
The management of testicular tumours represents a very dramatic success story in modern medicine. Approximately 85% of metastatic non-seminomas are cured, where 20 years ago the majority of patients with metastases died of their disease. Testicular cancer is thus viewed as the model of a curable malignancy and the principles of its treatment act as a guide to improve the management of other solid tumours. The second edition of this text has been revised and updated. The multidisciplinary approach to the management of testicular cancer is reflected in the contributors, who include surgeons, radiotherapists, medical oncologists and psychologists. The contents are supplemented in this second edition by the addition of new chapters on the molecular biology of germ cell tumours and the management of stage II non-seminoma. This work is aimed at anyone involved in the management of patients with testicular cancer.
Testicular germ cell tumours: an introductory overview. Advances in tumour imaging. Tumour markers. Molecular biology of germ cell tumours. A comparison of the biology and prognosis of seminoma and non-seminoma. Prognostic classification in metastatic non-seminoma. Management of stage I seminoma: radiotherapy. Surveillance for stage I seminoma of the testis. Management of metastatic seminoma: role of radiotherapy. Chemotherapy in metastatic seminoma. Response evaluation in seminoma. Management of stage I non-seminoma: surveillance and chemotherapy. Management of stage I non-seminoma: rationale for lymphadenectomy. Retroperitoneal lymphadenectomy in staging and treatment: the development of nerve-sparing techniques. Management of metastatic non-seminoma: development of effective chemotherapy. Management of stage II non-seminoma by lymphadenectomy. Primary chemotherapy for stage II non-seminoma. Toxicity reduction in the chemotherapy of metastatic germ cell tumours. Dose escalation of cisplatin in the chemotherapy of poor risk germ cell tumour patients. Intensive induction treatment for poor risk patients. Alternating regimes to overcome drug resistance in poor risk germ cell tumour patients. Salvage therapy and autologous bone marrow transplantation. Abdominal surgery postchemotherapy in metastatic non-seminoma. Thoracotomy postchemotherapy in non-seminoma patients. Malignant extragonadal germ cell tumours in adults. Diagnosis and management of carcinoma in situ of the testis. The acute and chronic toxicities of chemotherapy for metastatic testicular cancer. Psychological assessments and counselling of the patient with testicular cancer. Index.
| Erscheint lt. Verlag | 4.9.1998 |
|---|---|
| Zusatzinfo | 90 illustrations, index |
| Verlagsort | London |
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Urologie | |
| ISBN-10 | 0-412-61210-0 / 0412612100 |
| ISBN-13 | 978-0-412-61210-7 / 9780412612107 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
